Recruiting Fanconi Anemia Studies in Duluth
Improved Diagnosis of Familial Hypercholesterolemia Across the Northland (ID-FH)
The overall goal of this study is to promote awareness of Familial Hypercholesterolemia (FH). The investigators aim to enroll patients with suspected FH into the study and will randomize them to recei...
Wisconsin Ginseng for Decreasing Cancer Related Fatigue
This phase III trial compares the effect of Wisconsin ginseng (panax quinquefolius) to placebo in patients with cancer that suffer from significant fatigue. Fatigue is among the most challenging sympt...
About Fanconi Anemia Clinical Trials in Duluth
Fanconi anemia is a rare genetic disorder that affects bone marrow, reducing production of all types of blood cells and increasing cancer susceptibility. It is associated with physical abnormalities and organ defects. Treatment includes blood transfusions, growth factors, and stem cell transplant.
There are currently 2 fanconi anemia clinical trials recruiting participants in Duluth, MN. These studies are seeking a combined 460 participants. Research is being sponsored by Essentia Health, Mayo Clinic. Clinical trial participation is free and participants receive study-related medical care at no cost.
Fanconi Anemia Clinical Trials in Duluth — FAQ
Are there fanconi anemia clinical trials in Duluth?
Yes, there are 2 fanconi anemia clinical trials currently recruiting in Duluth, MN. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Duluth?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Duluth research site will contact you about next steps.
Are clinical trials in Duluth free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Duluth studies also compensate for your time and travel.
What fanconi anemia treatments are being tested?
The 2 active trials in Duluth are testing new therapies including novel drugs, biologics, and treatment approaches for fanconi anemia.
Data updated March 2, 2026 from ClinicalTrials.gov